MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-23-2026
West Pharmaceutical Services Depreciation & Amortization 2011-2026 | WST
Annual Depreciation & Amortization West Pharmaceutical Services
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 171 M | 155 M | 137 M | 121 M | 122 M | 109 M | 103 M | 104 M | 96.7 M | 90.7 M | 89.9 M | 90 M | 85.2 M | 76.9 M | 75.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 171 M | 75.7 M | 109 M |
Quarterly Depreciation & Amortization West Pharmaceutical Services
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.2 M | - | 43 M | 41.4 M | 40 M | - | 40.2 M | 38.9 M | 35.6 M | - | - | - | 30.7 M | - | 86.8 M | - | 28.7 M | - | 84.6 M | - | 28 M | - | 77.3 M | 50.1 M | 24.9 M | - | 74.6 M | 50.2 M | 24.9 M | - | 76.1 M | 50.6 M | 25.7 M | - | 69.9 M | 45.4 M | 22.6 M | - | 65.9 M | 43.7 M | 21.6 M | - | 63.6 M | 42.1 M | 21 M | - | 63.9 M | 42.6 M | 20.6 M | - | 59.9 M | 39.1 M | 19.4 M | - | 53.6 M | 35.2 M | 17.5 M | - | 53.9 M | 36.5 M | 18.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 86.8 M | 17.5 M | 44.1 M |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M |  USA |
 |
iRhythm Technologies
IRTC
|
20.7 M | $ 122.35 | - | $ 3.92 B | USA |
 |
Repro Med Systems
KRMD
|
810 K | $ 3.96 | - | $ 183 M | USA |
 |
Milestone Scientific
MLSS
|
78.2 K | $ 0.32 | 1.28 % | $ 26.3 M | USA |
 |
STERIS plc
STE
|
476 M | $ 221.8 | - | $ 21.9 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
1.57 M | $ 10.99 | - | $ 26.7 M | USA |
 |
Teleflex Incorporated
TFX
|
178 M | $ 136.56 | - | $ 6.09 B | USA |
 |
The Cooper Companies
COO
|
377 M | $ 64.42 | - | $ 12.8 B | USA |
 |
Utah Medical Products
UTMD
|
826 K | $ 67.17 | - | $ 218 M | USA |
 |
Haemonetics Corporation
HAE
|
116 M | $ 59.93 | - | $ 3.02 B | USA |
 |
electroCore
ECOR
|
501 K | $ 6.18 | -0.08 % | $ 52.4 K | USA |
 |
ICU Medical
ICUI
|
201 M | $ 124.82 | 0.22 % | $ 3.08 B | USA |
 |
Envista Holdings Corporation
NVST
|
116 M | $ 26.8 | - | $ 4.5 B | USA |
 |
Microbot Medical
MBOT
|
47 K | $ 2.2 | - | $ 101 M |  Israel |
 |
Isoray
ISR
|
3.25 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
600 M | $ 482.22 | - | $ 172 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
352 M | $ 11.91 | - | $ 2.37 B | USA |
 |
Glaukos Corporation
GKOS
|
33.7 M | $ 121.48 | - | $ 5.88 B | USA |
 |
Masimo Corporation
MASI
|
103 M | $ 178.63 | - | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
13.4 M | $ 10.34 | - | $ 214 M | USA |
 |
Merit Medical Systems
MMSI
|
123 M | $ 68.58 | - | $ 4.06 B | USA |
 |
Pulse Biosciences
PLSE
|
406 K | $ 23.02 | - | $ 1.55 B | USA |
 |
Retractable Technologies
RVP
|
7.77 M | $ 0.65 | - | $ 19.5 M | USA |
 |
Pro-Dex
PDEX
|
1.24 M | $ 52.1 | - | $ 171 M | USA |
 |
LeMaitre Vascular
LMAT
|
10.4 M | $ 113.45 | - | $ 2.57 B | USA |
 |
Predictive Oncology
POAI
|
129 K | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
8.32 M | $ 25.67 | - | $ 1.27 B | USA |
 |
BioLife Solutions
BLFS
|
5.16 M | $ 21.38 | - | $ 985 M | USA |
 |
Stereotaxis
STXS
|
626 K | $ 1.93 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
981 M | $ 18.16 | - | $ 9.32 B | USA |
 |
ResMed
RMD
|
160 M | $ 219.85 | - | $ 32.1 B | USA |
 |
AtriCure
ATRC
|
12.1 M | $ 29.28 | - | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
1.74 M | $ 6.86 | 1.18 % | $ 305 M | USA |
 |
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
25.8 M | $ 11.1 | - | $ 453 M | USA |
 |
Becton, Dickinson and Company
BDX
|
2.46 B | $ 152.14 | - | $ 43.8 B | USA |
 |
Nephros
NEPH
|
214 K | $ 2.87 | 1.06 % | $ 29.8 M | USA |
 |
OraSure Technologies
OSUR
|
10.2 M | $ 3.0 | -1.64 % | $ 220 M | USA |
 |
Repligen Corporation
RGEN
|
68.6 M | $ 117.6 | - | $ 6.55 M | USA |